Evidence map›Paper›PMID 34235314›Full record

ArticleACS omega2021

Adeno-associated Virus Virus-like Particle Characterization via Orthogonal Methods: Nanoelectrospray Differential Mobility Analysis, Asymmetric Flow Field-Flow Fractionation, and Atomic Force Microscopy.

Samuele Zoratto, Victor U Weiss, Gernot Friedbacher, Carsten Buengener, Robert Pletzenauer, Alexandra Foettinger-Vacha, Michael Graninger, Guenter Allmaier

Abstract read
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Samuele ZorattoInstitute of Chemical Technologies and Analytics, TU Wien (Vienna University of Technology), Vienna A-1060, Austria.
Victor U WeissInstitute of Chemical Technologies and Analytics, TU Wien (Vienna University of Technology), Vienna A-1060, Austria.ORCID https://orcid.org/0000-0002-0056-6819
Gernot FriedbacherInstitute of Chemical Technologies and Analytics, TU Wien (Vienna University of Technology), Vienna A-1060, Austria.
Carsten BuengenerPharmaceutical Sciences, Baxalta Innovations (part of Takeda), Vienna A-1221, Austria.
Robert PletzenauerPharmaceutical Sciences, Baxalta Innovations (part of Takeda), Vienna A-1221, Austria.
Alexandra Foettinger-VachaInstitute of Chemical Technologies and Analytics, TU Wien (Vienna University of Technology), Vienna A-1060, Austria.
Michael GraningerPharmaceutical Sciences, Baxalta Innovations (part of Takeda), Vienna A-1221, Austria.
Guenter AllmaierInstitute of Chemical Technologies and Analytics, TU Wien (Vienna University of Technology), Vienna A-1060, Austria.ORCID https://orcid.org/0000-0002-1438-9462

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adeno-associated virus (AAV)-based virus-like particles (VLPs) are thriving vectors of choice in the biopharmaceutical field of gene therapy. Here, a method to investigate purified AAV serotype 8 (AAV8) batches via a nanoelectrospray gas-phase mobility molecular analyzer (nES GEMMA), also known as an nES differential mobility analyzer, is presented. Indeed, due to AAV's double-digit nanometer scale, nES GEMMA is an excellently suited technique to determine the surface-dry particle size termed electrophoretic mobility diameter of such VLPs in their native state at atmospheric pressure and with particle-number-based detection. Moreover, asymmetric flow field-flow fractionation (AF4, also known as AFFFF) and atomic force microscopy (AFM) techniques were employed as orthogonal techniques for VLP characterization. In addition, AF4 was implemented to size-separate as well as to enrich and collect fractions of AAV8 VLPs after inducing analyte aggregation in the liquid phase. Bionanoparticle aggregation was achieved by a combination of heat and shear stress. These fractions were later analyzed with nES GEMMA (in the gas phase) and AFM (on a solid surface). Both techniques confirm the presence of dimers, trimers, and putative VLP oligomers. Last, AFM reveals even larger AAV8 VLP aggregates, which were not detectable by nES GEMMA because their heterogeneity combined with low abundance was below the limit of detection of the instrument. Hence, the combination of the employed orthogonal sizing methods with the separation technique AF4 allow a comprehensive characterization of AAV8 VLPs applied as vectors.

Identifiers

PMID34235314
PMCPMC8246466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.